Eprosartan

This classification denotes an angiotensin ii receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2KH13Z0S0Y. European Medicines Agency schedules Eprosartan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06586MIG. Eprosartan generally arises in the molecular formula C23H24N2O4S. The term EPROSARTAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, no. 3, 1995, list 35.) EPROSARTAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule eprosartan under HS 29349990 and SITC 51579. As of Q4 2014, EPROSARTAN remains the US FDA Preferred Term for this commodity. Eprosartan bears US NLM identifiers UMLS ID C0287041 and NCI Concept Code C61749. SMILES: s1c(C/C(=C/c2n(c(nc2)CCCC)Cc2ccc(cc2)C(=O)O)C(=O)O)ccc1.